Thermo Fisher Scientific (TMO) Q3 results:
Revenues: $6,272M (+5.9%); Life Sciences Solutions: $1,701M (+13.1%);
Analytical Instruments: $1,358M (+1.9%); Specialty Diagnostics: $879M
(-1.7%); Laboratory Products and Services: $2,619M (+6.0%).
Net Income: $760M (+7.2%); EPS: $1.88 (+7.4%);
non-GAAP Net Income: $1,187M (+11.4%); non-GAAP EPS: $2.94 (+12.2%); CF
Ops: $3,060M (+11.6%).
2019 Guidance: Revenue: $25.34B – 25.50B from $25.30B – $25.50B; Non-GAAP EPS: $12.28 – 12.34 from $12.16 – 12.26.
https://seekingalpha.com/news/3508197-thermo-fisher-beats-q3-consensus-guidance-raised
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.